Vivani Reports Q3 2026 Financial Results
Vivani Medical announced financial results for Q3 2026 and provided an update on its SLIM-1 Phase 1 clinical trial and the pending sale of Cortigent-ClearOne, signaling continued progress in GLP-1 therapy development.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed